tirzepatide in egypt Eli Lilly launches weight-loss drug Mounjaro India after drug regulator green light Mounjaro 15 mg 1 Pen

Accessed: Jun

This approval, based on the positive results from the SURMOUNT-CN clinical trial, makes tirzepatide the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for obesity treatment in China, which is expected to enhance its market positioning in the country, says GlobalData

So, theres going to be a wide spectrum of winners and losers in the food industry from the growth of GLP-1 drugs: some companies will be very negatively impacted, others might see little impact, while others could even benefit

A four-letter peptide drawn from the pineal gland

Some users experience tingling or numbness in the hands and feet (carpal tunnel-like symptoms) from fluid shifts

Small, frequent meals often work better than large meals, particularly during the initial treatment weeks